-690x550.jpg)
FRIDAY, Nov. 22, 2024 (HealthDay News) — How long Americans can expect to live varies dramatically — and the gap continues to widen. A new report says health inequalities have, in essence, created 10 Americas. These mutually exclusive populations are divided along familiar fault lines, including race, ethnicity, income andContinue Reading
FRIDAY, Nov. 22, 2024 (HealthDay News) — America’s kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, a new study shows. GLP-1s like Ozempic, Wegovy, Mounjaro and Zepbound all work by making food less desirable, and it’s showing up in more foodContinue Reading
THURSDAY, Nov. 21, 2024 (HealthDay News) — A drug used to help patients lose weight and manage diabetes may also help those with heart failure, an international clinical trial shows. The test of tirzepatide, brand named Zepbound, included 731 patients with diastolic heart failure and obesity who were followed forContinue Reading
FRIDAY, Nov. 15, 2024 (HealthDay News) — Four out of five men and women in the United States will be overweight or obese by 2050 if current trends hold, a new study warns. About 213 million Americans aged 25 and older will be carrying around excess weight within 25 years,Continue Reading
WEDNESDAY, Nov. 13, 2024 (HealthDay News) — Bottoms up: The type of alcohol you prefer may say something about your lifestyle, new research reveals. Beer drinkers are more likely to have an unhealthy lifestyle than folks who prefer wine or liquor, scientists report. Beer drinkers have lower-quality diets, are lessContinue Reading
WEDNESDAY, Nov. 13, 2024 (HealthDay News) — Obesity, alcohol use and other factors are driving up rates of fatty liver disease among American adults, new research warns. By 2018, federal data showed that 42% of adults had some form of fatty liver disease — higher than prior estimates, according toContinue Reading
WEDNESDAY, Nov. 13, 2024 (HealthDay News) — High blood pressure is a rare health issue among teens, but U.S. case numbers are creeping upwards. Now, research published recently in the Journal of the American Heart Association, shows that healthy sleep can help keep hypertension at bay in the young. That’sContinue Reading
MONDAY, Nov. 11, 2024 (HealthDay News) — The weight-loss drug Ozempic can help reduce stroke patients’ risk of a heart attack or death, a new study says. GLP-1 weight-loss drugs like Ozempic or SGLT2 diabetes medications like Jardiance or Farxiga both helped protect the health of people following a stroke,Continue Reading
MONDAY, Nov. 11, 2024 (HealthDay News) — Lives lost to obesity-related heart disease have nearly tripled over the past twenty years, a new study reports. Heart disease deaths linked to obesity increased 2.8-fold between 1999 and 2020, according to findings presented today at the American Heart Association’s annual meeting inContinue Reading
SATURDAY, Nov. 9, 2024 (HealthDay News) — It may seem counter-intuitive, but losing weight without even trying may not be a good thing. “It’s not typical to have a noticeable drop in weight without changing how much you’re eating, being more physically active or trying to lose weight,” said dietitianContinue Reading
THURSDAY, Nov. 7, 2024 (HealthDay News) — The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of the active ingredient in those medications have now been linked to at least 100 hospitalizations and 10 deaths. “Honestly, I’m quite alarmedContinue Reading
WEDNESDAY, Nov. 6, 2024 (HealthDay News) — Nearly 16% of American adults — that’s close to 1 in 6 — now has diabetes, according to the latest data from the U.S. Centers for Disease Control and Prevention. Increasing age and widening waistlines greatly increase the odds for the disease, whichContinue Reading
-690x550.jpg)
WEDNESDAY, Nov. 6, 2024 (HealthDay News) — Women who are pregnant but who also have the ovarian cyst disorder polycystic ovary syndrome (PCOS) are at higher odds of giving birth to an underweight baby, new Norwegian research shows. The risk rises even higher if the woman with PCOS is alsoContinue Reading
TUESDAY, Nov. 5, 2024 (HealthDay News) — Poorer folks’ access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found. Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered. Under the Medicaid system, individual states areContinue Reading